Login
$PACB
$2.83 +$0.38 (15.51%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Jim R. Gibson
Chief Financial Officer
57 Since 2025
1 year
2025 $3,493,189
Mark Van Oene
See Remarks
Title from the Form 4 dated Aug 17, 2026
53 Not stated 2021 $2,366,113
James R Gibson II
See Remarks
Title from the Form 4 dated Oct 6, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 23, 2026 · updated by the 8-K of Jul 9, 2026

Directors
9
serving now
Independent
8 of 8
stated in the proxy; 1 not stated
Average tenure
11.4 years
from year joined
CEO also chairs the board
No
John F. Milligan
Director Age On board Independent Committees Other public boards 2025 pay Source
John F. Milligan
65 2013
13 years
Independent
Audit Compensation
None stated Not stated
Christian O. Henry
58 2018
8 years
Not stated None stated None stated Paid as CEO
Chris Gibson
43 2026
0 years
Independent
Science and Technology
None stated Not stated
William Ericson
67 2004
22 years
Independent
Compensation · Chair
None stated $108,554
Kathy Ordoñez
75 2014
12 years
Independent
Compensation
None stated $106,554
Randy Livingston
72 2009
17 years
Independent
Audit Corporate Governance and Nominating
None stated $105,570
Marshall Mohr
70 2012
14 years
Independent
Audit · Chair Compensation
None stated $115,538
Hannah A. Valantine
74 2021
5 years
Independent
Corporate Governance and Nominating
None stated $99,554
Lucy Shapiro Leaving at the meeting
Not stated Not stated Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 23, 2026
Stanford University
Randy Livingston was the Vice President for Business Affairs of Stanford University through December 2025 and Chief Financial Officer of Stanford University through September 2025; Lucy Shapiro, Ph.D. is the Director of the Beckman Center for Molecular and Genetic Medicine at Stanford University's School of Medicine; Hannah A. Valantine, M.D. is a Professor of Medicine (Cardiovascular) at the Stanford University Medical Center
Approximately $232,000
2025

Company recognized revenue relating to Stanford University in 2025

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support